chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chickenpox type rash on several areas of body. Rash began on right buttocks, moved to left side of upper back and right forearm. There is a little in left forearm. It is now 09/21, and itchy rash still exists on right forearm, with more breaking out overnight. I have used SARNA LOTION and cold cloths to ease the itching.
Received a dose of the vaccine past expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a dose of the vaccine past expiration date) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a dose of the vaccine past expiration date). On 18-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Received a dose of the vaccine past expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No treatment medications were reported. Vaccine was stored in refrigerator on 16Sep2021 and administered to patient on 18Sep2021  Reporter did not knowtotal amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77° F) because she was not there that day, but supposes about 4 hs.
WHEEZING, FEELING OF CHOKING, AND DIFFICULTY BREATHING, SEVERE NAUSEA.
Pt received flu shot on 9/18/15 with no side effects. On 9/28 he complained of weakness and chills. Says he has never experienced this before. No fever, no sweats. Called pharmacy 9/30 4:20 PM.
Lightheaded, sweating Seen by onsite EMT ICE pack on neck, pt. laying on stretcher Pt. released at 09:28 A.M. recorded by RN
Chills; aching; severe headache; nausea; This is a spontaneous report from a Pfizer-sponsored program and contactable consumer. A 50-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 14Feb2021 at 08:45 (at the age of 50-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Medical history included weight increased (Just Heavy weight) from an unknown date and unknown if ongoing. No concomitant medication was reported. Other products, patient History and investigation assessment reported as no. History and Investigations: No. Patient received 2nd dose of COVID vaccine Sunday morning on 15Feb2021 at 8:45AM, the patient experienced minor symptoms pain, chills and aches. Has not taken anything for pain but would like to know if patient can take something such as Tylenol or Advil. Patient did not have any underlying conditions. Since midnight has had many of the common symptoms such as nausea, aching, chills and severe headache. Wants to know if he can take a Tylenol. Patient needs the Tylenol. Did not want to do anything that was advised against. The outcome of the events were unknown.   Follow-up attempts completed. No further information expected.
Itching,hives, face & neck;hot flushed skin;numbness in face & neck;
flu like symptoms; fever; Achiness; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th January 2020, the patient received Shingrix. In January 2020, less than a week after receiving Shingrix, the patient experienced influenza-like symptoms, fever and pain. On an unknown date, the outcome of the influenza-like symptoms, fever and pain were not recovered/not resolved.   It was unknown if the reporter considered the influenza-like symptoms, fever and pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient received vaccine a day before reporting. Post vaccination the patient had fever, achiness and flu like symptoms. The patient inquired that how long do the flu like symptoms last and was there a timeframe that the symptoms typically go away.
Pt recvd vax approx 9AM mom called 11AM pt had fever, c/o h/a, vomiting sent to ER & family MD; MD stated pt had viral illness; sent pt home on APAP;
Information has been received from a consumer concerning her daughter who in approximately April 2007, was vaccinated with her first dose of GARDASIL. A couple weeks after the first vaccination the daughter began to experience vasovagal syndrome, vomiting, and fainting. Her daughter received all three doses of GARDASIL and the AE worsened after each vaccination. She has also had night sweats. The daughter is home bound and cannot attend school. The third vaccination was given in November 2007. The patient has not recovered. She has had blood work, other unknown tests and a heart monitor. She has sought medical attention in the doctors office. Additional information has been requested.
Received two doses of HPV vaccine. In the following months began to lose weight, lose hair, then experience pleurisy in the lungs. By March of 2018,  was experiencing more symptoms including arthritic and muscular pain, migraines, fever. Was diagnosed with Lupus SLE in May of 2018. Continue to have active lupus and now lupus nephritis.
A report was received from a health care professional on 12/12/03 concerning a 2 year old female vaccinee who was inadvertently administered Fluvirin on an unknown date. On an unknown date, a vaccinee was inadvertently administered Fluvirin. No adverse events had occurred as a result of this, at the time of this report. There was insufficient information to determine the reporter's causality assessment. Update 1/26/04: A follow up report received from a health care professional confirmed that the vaccinee received Fluvirin on 12/5/03. No follow up information pending.
Patient became extremely lethargic and began sweating profusely, however temperature remained normal at 97.1F upon checking. Patient stated they were lightheaded and repeatedly stated ?help me...help me?. Patient remained conscious throughout the event and stated she had no trouble breathing.  Patient was given a few sips of water and was instructed to remain seated. After asking the patient they elected to have us call emergency services. Upon arrival of emergency services patient stated that she was feeling better. Emergency services did not find anything wrong and no further action was necessary. Patient elected to go home.
Administration of Boostrix to a 5 month old patient; Pt was given Boostrix instead of Infanrix; This case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 5-month-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 57gj2, expiry date 29th May 2023) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 28th December 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 28th December 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The health care professional called to report that a 5 month old patient was inadvertently administrated Boostrix which led to inappropriate age at vaccine administration and wrong vaccine administered. The patient was supposed to received Infanrix. No further events were reported.  The health care professional agreed to be contacted for follow up.
Became dizzy roughly 5 minutes after injection. Drank water, sat in a chair outdoors for about half an hour until symptoms passed.
Patient presented on 5/20/22 for 2nd booster of Moderna.  The next evening partner reported patient awoke several times overnight (sat/sun) asking for his inhaler, use of which was helpful. Then he became unresponsive and cyanotic. The EMTs declared him deceased at home. It is unknown if the Booster administration was related.
patient get the shot get sick; Initial information was receive on 11-Feb-2021 regarding an unsolicited valid non-serious social media case from the consumer/non-health care professional.  This case involved an unknown age female patient who got the shot get sick (illness), after she received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination and family history not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got sick (illness), (latency: unknown) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown at the time of reporting.  There will be no information available on the batch number for this case
Cough, sinus pressure, body covered in rash, fever, hard time breathing, white splotches on skin.
Saturday developed cough and chills, and tired continued into Sunday. Still have dry cough Monday morning
36 hrs. after injection woke up in night with radiating headache in back of head between my ears. <3 min later, felt a fast swelling in my chest like a balloon and started convulsively shaking took tempature-97.8. Took 2 tylenol and prayed. Called nursline the next day.
Redness, swelling, painful injection site still present (24+hrs)  Fever of 102.
Chest pain; Pressure in head & face; Pressure in head & face; Pains in nape, across the shoulders and front/top head; Weakness in arms right worse than left; Tingling in right hand; Nausea; Salty taste in mouth; Elevated blood pressure; Dry mouth; Indigestion; This is a spontaneous report from a contactable consumer (patient herself). A 66-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3246), via an unspecified route of administration in left arm at the age of 66-years (non-pregnant at the time of vaccination), on 01Feb2021 at 08:00 AM at a single dose for COVID-19 immunization. The patient's medical history included osteopenia and allergies to PCN (penicillin) and latex. Concomitant medication included glucosamine, curcuma longa (TURMERIC [CURCUMA LONGA]), fish oil (OMEGA 3 [FISH OIL]), calcium citrate (CITRACAL [CALCIUM CITRATE]), colecalciferol (VIT D3), cranberry, and biotin. The patient previously took first dose of bnt162b2 (Lot number: EK9231), via an unspecified route of administration in left arm at the age of 66-years, on 13Jan2021 at single dose for COVID-19 immunization. The patient received other vaccine in four weeks was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID. The patient experienced pressure in head & face, pains in nape, across the shoulders and front/top head, weakness in arms right worse than left, tingling in right hand, nausea, salty taste in mouth, elevated blood pressure, dry mouth, and indigestion on 05Feb2021. The patient also experienced chest pain on 10Feb2021. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included blood pressure measurement on 05Feb2021: elevated; nasal swab on 11Feb2021: pending result. The patient received paracetamol (TYLENOL) and ibuprofen (ADVIL) as treatment for the events. The patient also used heating pad and icepack as treatment for the events. The outcome of the events was not recovered.
Pt rec'd Td 6/22/01 after stepping on rusty nail 6/19/01. Called dept 6/25/01 8:30am complaining of fever 104.0F and body aching. Saw her Dr 6/27/01 and was told reaction to Td.
Left upper arm swollen, warm to touch, 5cm diameter, Cellulitis-Keflex 500 TID X 10 day.
large area of redness and itching at injection site. Treated with Benadryl and Cortisone cream.
PT HAD NUMBNESS IN THE LEFT ARM, LAST 2 FINGERS WERE NUMB
pt recv vax & had sl malaise, muscle aches, w/malaise, sore throat, h/a;
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult male patient who received SHINGRIX for prophylaxis. In November 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain, pain in joint involving shoulder region and mobility decreased. On an unknown date, the outcome of the injection site pain, pain in joint involving shoulder region and mobility decreased were not recovered/not resolved. It was unknown if the reporter considered the injection site pain, pain in joint involving shoulder region and mobility decreased to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. After receiving the SHINGRIX vaccine, the patient experienced  injection site pain which never went away. The pain moved up into the joint of the shoulder limiting the movement of the shoulder. The patient stated that, he was awakened by the ache from the shot In January 2019, the patient had the 2nd dose of SHINGRIX. The patient stated that nothing had changed between the 1st and 2nd injection. The patient stated that ached before the 2nd injection, and continued to ache at about the same amount after the 2nd injection.
High fever reaching at least 103.8 overnight following  receiving the vaccine that morning.  Fever accompanied by chills,, shaking, headache, rapid heart rate, and sweats continuing until approximately 8:00 am the following morning.  Fatigue  lingering after fever broke for 2-3 more days.
Hurts a lot; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR053700   Additional Information: GSK Receipt Date: 23-Mar-2022 Reporter's Comments: This case was received from consumer via interactive digital media.  Additional Supportive Information: The patient self-reported this report. The patient called and stated that received 2 doses of Shingrix and hurts a lot but supposed to be vastly better than the earlier one. For tolerance of 2nd dose, refer case US2022AMR053700.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR053700:Same Reporter
This spontaneous report as received from a nurse refers to a male patient of unknown age. The reporter reported that the patient received a first dose of GARDASIL (lot # was not reported) on 27-NOV-2012, the second dose of GARDASIL (lot # was not reported) on 07-FEB-2013 and a third dose of GARDASIL (lot # was not reported) on 25-FEB-2013. No adverse symptoms reported. Additional information has been requested.
Pt received her Flu shot from Pharmacist, on Sunday 11/25/18 around 11:00AM. Pt had forewarned she gets dizzy from vaccines while reviewing consent form. Pt received shot in our immunization room while sitting on armed chair while her father was next to her. Pt's father and pharmacist remained in room. After administering shot in her left shoulder, and placing bandage, pt claimed she was fine.  After about 1 minute, she started sweating profusely on face/neck and her face became visibly red.  During conversation, she stated her vision was impairing as her view of her dad's face was becoming hazy/fuzzy, and her speech was slurred while stating that. Pharmacist gave bottle of cold water. After drinking water, she started to feel better. Redness on face was visibly lessening and patient reported not feeling sweaty any longer. After about 3 more minutes, patient was able to converse clearly and visibly looked less weak. After another 2 minutes, when patient stated she was "much better", pharmacist informed pt/Father to remain in room for another 5 minutes and went inside pharmacy.  After a few minutes, when pt/Father left the immunization room, pharmacist asked them report back to pharmacy after their shopping trip is complete just to ensure pt was fine. After 10 minutes or so, once their shopping was completed, pt and her father waved bye to pharmacist in pharmacy on their way out.
This was a booster to my J&J COVID-19 vaccine that was received 4/9/2021 at the same pharmacy. On 1/6/22 I began with difficulty breathing and coughing followed by a temp of 102+ that lasted two days. Symp worsened and by 1/10, I called urgent care. At appoint on 1/11/22, COVID-19 test (rapid via nostril) was negative and no meds given.  Throughout the next week the symptoms worsened (body aches, diaphragm was bruised making it difficult to breathe/move, headache, coughing, low energy, increased hearing loss and intermittent fever). Without improvement, on 1/17 called for additional testing and follow-up appointment. Additional information for Item 18:  (CONT)  At the Urgent Care I got a negative rapid test, however, this time, the Urgent Care Dr. diagnosed me with severe bronchitis and prescribed antibiotic and decongestant.  On that same day, at a different location, I took a 48 hour COVID-19 test.  That test also came back negative for COVID-19.  Even with the new medication, I continued to be limited on my ability to move due to the soreness of the diaphragm and chest.  I was out of work from 1/7 through aprox 2/10/2022. Though my health improved slowly with diaphragm pain ceasing aprox Feb 12, coughing continued until May 2022.  Although my hearing had initially been deteriorating starting in aprox Oct 2021, after this booster, the hearing loss was significant, so my Primary Care Physician referred me to an audiologist. On Feb 09, 2022 I received a hearing test from Audiologist, which revealed substantial hearing loss in Left ear while Right ear was 100% healthy.  PCP also ordered a head/brain MRI with contrast that was conducted 2/28/22 and revealed no abnormalities.   July 2022: Breathing has returned, though not to my pre vaccine levels.  I experience shortness of breath from routine exercise - a reduction from pre-vaccination.  Hearing continues to be reduced, but perhaps not as bad as in the first half of 2022.  Headaches continue more frequently than prior to COVID vaccines.   I participated in the V-Safe Program for each of my COVID vaccines, however due to the dates of status check, this info wasn't reported until  July 2022.  * All of this is provided as information.  I am not medically qualified to associate these issues with the vaccine, however my health has been impacted by the vaccines in the ways described above.   **I had a severe reaction to the J&J vaccine in Apr 2021. IF an adverse report should be completed to describe the reaction, please notify me.  Thank you. <<<end of message>>>
This spontaneous report as received from a registered nurse refers to a 74 year old patient. On 28-JUN-2013 the patient was vaccinated subcutaneously with a 0.5 ml dose of VARIVAX (Merck) (Lot # not reported), instead of ZOSTAVAX. No adverse effect reported. It was not known if the patient sought medical attention. Additional information has been requested.
Eyes glassy wants to be held, lethargic, decreased appetite, moaning (cry is different) rectal temp 100.6. No sick contacts, no sz notice.
Itchy rash/hives first appeared on elbows/forearms. Hives continued to spread in following order: entire forearm, knees, calves, thighs, back, upper chest/neck area. The hives spread over the course of 3 days until 10/19/2015. Each individual hive/cluster of hives lasted approx. 24 hrs. Also experienced swollen fingers and toes on 2nd & 3rd day (10/17/15 & 10/18/15). Treated with Benadryl at maximum recommended dosage. Most hives disappeared by 10/19/15. Some lingering breakouts of individual hives on arms & legs.
Patient arrived to obtain 2nd dose of primary series of vaccine.  patient received as 2nd dose the Pfizer Bivalent rather than a Prime dose.
Patient received pneumovax on 8/14/02. Patient phoned clinic on 8/15/02 and reports aching all over, headache, unable to eat. The injection site is red. On 8/16/02 the patient returned to the clinic. The right upper arm was red and swollen with soreness at the injection site. Some soreness on right upper arm near shoulder also.
Administered expired Moderna COVID-19 vaccine; Vial was initially stored in refrigerator on 16Dec2021 and administered on 04 Mar 2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 16Dec2021 and administered on 04 Mar 2022) in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 16Dec2021 and administered on 04 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 16Dec2021 and administered on 04 Mar 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product use was provided.  Date the vial was initially stored in the refrigerator was 16-Dec-2021 and the vial did not undergo any temperature excursions.  No treatment medication was provided.